TREVI THERAPEUTICS INC's ticker is TRVI and the CUSIP is 89532M101. A total of 18 filers reported holding TREVI THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $147 | -31.0% | 67,300 | -24.6% | 0.00% | – |
| Q2 2023 | $213 | -51.5% | 89,300 | -62.4% | 0.00% | -100.0% |
| Q1 2023 | $439 | -28.5% | 237,400 | -25.3% | 0.00% | 0.0% |
| Q4 2022 | $614 | -99.9% | 318,000 | -24.1% | 0.00% | 0.0% |
| Q3 2022 | $646,000 | +51.6% | 419,187 | +176.7% | 0.00% | 0.0% |
| Q2 2022 | $426,000 | +67.1% | 151,500 | +30.6% | 0.00% | – |
| Q1 2022 | $255,000 | -3.4% | 116,000 | -65.6% | 0.00% | – |
| Q4 2021 | $264,000 | +187.0% | 337,400 | +415.1% | 0.00% | – |
| Q3 2021 | $92,000 | -55.8% | 65,500 | -29.3% | 0.00% | – |
| Q2 2021 | $208,000 | -37.0% | 92,600 | -24.0% | 0.00% | – |
| Q1 2021 | $330,000 | +432.3% | 121,849 | +374.1% | 0.00% | – |
| Q4 2020 | $62,000 | – | 25,700 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| NEA Management Company, LLC | 11,370,376 | $24,787,420 | 1.91% |
| Fairmount Funds Management LLC | 5,163,287 | $11,255,966 | 1.35% |
| Opaleye Management Inc. | 1,705,900 | $3,718,862 | 1.21% |
| Frazier Life Sciences Management, L.P. | 6,881,090 | $15,000,776 | 1.00% |
| VR Adviser, LLC | 3,422,397 | $7,460,825 | 0.78% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 927,415 | $2,021,765 | 0.61% |
| Rubric Capital Management LP | 5,684,420 | $12,392,036 | 0.46% |
| Tejara Capital Ltd | 180,227 | $392,895 | 0.22% |
| PFS Partners, LLC | 100,000 | $218,000 | 0.19% |
| WealthTrust Axiom LLC | 93,500 | $203,830 | 0.07% |